Tag: NET cancer blogs
1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …
READ MORE
CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals
Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…
READ MORE
RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients
Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund. According to Ebrahim…
READ MORE
Carcinoid Cancer Foundation Asks You to Help Support Rare Disease Day: Write Your Reps Campaign
Carcinoid patients, physicians, family, friends and colleagues can help support Rare Disease Day 2011 by participating in NORD’s Write Your Reps Campaign. NORD (National Organization for Rare Diseases) and its advocacy partners have worked with…
READ MORE
California Governor Calls for Increased NET Cancer Awareness & Research
Governor Arnold Schwarzenegger of California is the 11th United States Governor to support NET cancer awareness. In his November 10, 2010 letter to the Northern California Neuroendocrine Cancer Fighters, a support group for carcinoid and NET cancer…
READ MORE
